Εκπαιδευτικά προγράμματα
Λίστα αντικειμένων

Journal of Clinical Oncology. 2021 Apr 27;
National Marrow Donor
Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched
Unrelated Donor Bone Marrow Transplantation Using Post-Transplant
Cyclophosphamide.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns,
Brent R Logan, Farhad Khimani, Brian C Shaffer, Nirav N Shah,
Alisha Mussetter,...


Cancer. 2021 Mar 18;
Acute myeloid leukemia:
Treatment and research outlook for 2021 and the MD Anderson
approach.
Hagop M Kantarjian, Tapan M Kadia, Courtney D DiNardo, Mary
Alma Welch, Farhad Ravandi
PMID: 33734442
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Excellent case based report on npm1 Mut Aml
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Comprehensive review for AML treatment. New directions
applied in MD Anderson CC
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


New guidelines for treatment of MM (EHA/ESMO)
Presenter S. Kastritis
Participation Spyridonidis, Liga, Tsokanas
Diagnostic obligatory are still Free light chain serum, 24-Urin,
cytogenetics (Del17p, t(4,14), WBLD-CT and if negative Whole
body MRI.
Asymptomatic MM (use 20/2/20 score), if high (2 of 3) risk score
these pats...


https://www.ebmt.org/sites/default/files/2021-02/EBMT%20COVID-19%20guidelines%20v.%2015.02%202021-02-18.pdf
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Ebmt proposes to vaccinate after day 100
https://www.ecdc.europa.eu/en/publications-data/coronavirus-disease-2019-covid-19-and-supply-substances-human-origin
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


An important paper published in Blood showed that prophylaxis
is not
always wihtout harm. Pts under letermovir prophylaxis may be
at risk for
late CMV infection after HCT because of delay CMV-specific
cellular
reconstitution (which is due to the letermovir induced
decreased CMV
antigen exposure).
JOURNAL ARTICLE
Cytomegalovirus-specific T-cell Reconstitution...


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


New England Journal of Medicine. 2020 Dec 24; 383 (26) :
2526-2537.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in
First Remission.
Andrew H Wei, Hartmut Döhner, Christopher Pocock, Pau Montesinos,
Boris Afanasyev, Hervé Dombret, Farhad Ravandi, Hamid Sayar, Jun-Ho
Jang, Kimmo Porkka, Dominik Selleslag,...


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


https://register.gotowebinar.com/register/6711366611927088656
Stem Cell Transplantation - a Post ASH 2020
Summary
Tuesday, February 2, 2021
Professor Arnon Nagler, MD, MSc
Participants: Prof.Spyridonidis, Dr Liga, Dr Tsokanas, Dr
Lekka


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Duration of shedding of viable SARS-CoV-2 in severely
immunosuppressed patients with
cancer
For most patients with COVID-19, persistently positive
nucleic acid
testing after symptom resolution does not indicate
prolonged
infectiousness. However, accumulating evidence suggests that
some
severely immunocompromised patients may have prolonged
shedding of
viable SARS-CoV-2. One study of 20 patients with...


Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Study showing the different significance of allelia or Niall
epic tp53 mutation in AML as recently showed in MDS
Presenter: Prof.Spyridonidis
Participants: Dr Liga, Dr Tsokanas, Dr Lekka


Βρέθηκαν 404 αποτελέσματα. Σελίδα 7 από 21

